By Kristina M. Launey

As noted during our Healthcare webinar last week, the accessibility of drug labels accessible is on the Administration’s agenda.  Yesterday the Access Board announced that the stakeholder working group it organized to develop best practices for making drug labels accessible will hold its first public meeting January 10 and 11 in Washington, D.C., to explore best practices for making information on prescription drug container labels accessible to people who are blind or have low vision or who are elderly.  More information about the meeting can be found here.